Table 2 Baseline echocardiographic characteristics of study population according to left ventricular remodeling status at follow up (left ventricular hypertrophy vs. non-left ventricular hypertrophy, left ventricular enlargement vs. non-left ventricular enlargement)
Characteristic | All subjects (n = 474) | Groups | P-value | Groups | P-value | ||
|---|---|---|---|---|---|---|---|
LVH (n = 49) | Non-LVH (n = 425) | LVE (n = 55) | Non-LVE (n = 419) | ||||
LVMI (g/m2.71) | 35.91 (30.41, 41.36) | 51.42 (48.42, 56.53) | 34.79 (30.09, 39.51) | 0.000 | 47.21 (40.10, 55.12) | 34.87 (30.0, 39.67) | 0.000 |
LVM (g) | 12 | 176.19±21.29 | 122.81±25.18 | 0.000 | 160.31±17.26 | 124.10±23.77 | 0.000 |
RWT | 0.35±0.05 | 0.36±0.05 | 0.34±0.04 | 0.133 | 0.30±0.04 | 0.35±0.05 | 0.000 |
LVEF (%) | 64.44±3.51 | 62.83±3.01 | 63.51±3.57 | 0.135 | 63.78±3.36 | 64.53±3.51 | 0.124 |
E/e’ ratio | 12.5 (9.09, 16.6) | 14.28 (11.11, 18.0) | 12.5 (9.09, 16.66) | 0.080 | 13.46 (11.5, 16.6) | 12.5 (8.33, 16.6) | 0.019 |
E/A ratio | 1.12±0.32 | 1.02±0.18 | 1.12±0.24 | 0.088 | 0.96±0.22 | 1.14±0.16 | 0.127 |
LAD (mm) | 34.73±5.41 | 36.31±3.81 | 34.50±5.51 | 0.006 | 36.71±4.56 | 34.46±5.64 | 0.003 |
LVIDd (mm) | 46.66±4.13 | 50.73±3.79 | 46.17±3.89 | 0.000 | 52.62±2.70 | 45.86±3.61 | 0.000 |
PVWT (mm) | 8.05±1.06 | 8.98±1.30 | 7.03±0.98 | 0.000 | 8.05±1.27 | 8.01±1.02 | 0.670 |
IVST (mm) | 8.56±1.24 | 10.08±1.26 | 8.38±1.11 | 0.000 | 8.97±1.57 | 8.11±1.17 | 0.036 |